Specifically, Boston leads the way in embracing new research models (for example, Research at the Broad Institute of Harvard and MIT) and, in building a new research culture that has strong roots in academia and the pharma sector. A recent contribution of US$650 million as the philanthropic donation to Broad is the true testimony. It […]
“Don’t worry, you’ll outgrow it!” “Asthma? You’re too old for that.” If you’ve heard either of these statements from friends or family, your frustration is certainly understandable. Although it is true that some adults outgrow their asthma symptoms and fewer adults suffer from the condition versus children, the fact remains that approximately 18 million adults […]
There has been an upsurge in the economics of Pharma industry. Physicians, public health officials, hospital administrators and other health experts are becoming progressively more conscious about informed systematic analyses of the problems of financing, organizing and distributing health services. On the other hand, economists are discovering the importance of economic and challenge of healthcare. […]
Banner Advertisements are the form of online advertising through banners. They play a significant role in bringing traffic to your website. Pharma Focus Asia banner advertisements will revolutionize businesses and help companies to improve their business. Our banner ads will revolutionize businesses personalized experience and enhance visibility among the customers. Pharma Focus Asia banner advertising […]
Did you ever think how people can find you on the internet? How can you reach to people when your advertisements fail to gain their attention? Logically speaking, is it possible for people to find out your products or services without searching? Here comes our dynamic solution to this problem. You can reach to your […]
Condition: Estrogen Receptor (ER)-Positive, HER2-Negative Postmenopausal Effectiveness: ★★★ Ease of Use: ★★★ Satisfactory Index: ★★★ Therapeautic drug, Ibrance (Chemical name: Palbociclib), recently approved by the U.S. Food and Drug Administration in February 2015, is intended to be paired with the hormonal therapy medicine Femara (Chemical name: Letrozole) as a comprehensive treatment for locally advanced-stage or metastatic, hormone-receptor-positive, HER2-negative […]
The incidence of Central Nervous System (CNS) illness is on the upswing and exacts a heavy human and economic toll. According to the World Health Organization, more than 120 million people worldwide suffer from depression, and the number is expected to rise. The occurrence of Alzheimer’s disease is slated to grow by more than 100 […]
Over the past decade there has been increasing pressure on the pharmaceutical industry to increase economic efficiencies in drug discovery. This has been driven by several factors including the increased costs of R&D, lower productivity, patent expiration, generic competition and the increasing difficulty in bringing new chemical entities to market. The extraordinary investment requirements have […]
Edward Jenner’s work in developing the world’s first smallpox vaccine in the 1790s demonstrated that it was possible to protect the general population from major threats to public health, and vaccine development aimed at combating the major concerns of the day has continued ever since. There have been many successes, and vaccines are now available […]
Why are some firms more competitive than others? This is the central question of my research in the field of strategic management. Decades of research, in both the life sciences and other industries, have converged to suggest there are perhaps three overarching reasons. The first is the most obvious: what academics call the ‘Resource-Based View […]